ALKERMES, INC.

Health Issues

Awareness of the need for treatment system reform and access to all FDA-approved medications; Support patient-centered care and treatment that ensures comprehensive care and access to all FDA approved treatments; Awareness of outcomes data and the need for training on all medication assisted treatment; H.R. 7667 & S. 4348 - Prescription Drug User Fee Agreement reauthorization Awareness of need for transparency and patient access within the 340B program H.R.2617 - Consolidated Appropriations Act, 2023

TargetedSENATE · HOUSE OF REPRESENTATIVES · Executive Office of the President (EOP) · Office of Natl Drug Control Policy (NDCP) · Health & Human Services, Dept of (HHS) · Natl Institutes of Health (NIH) · Substance Abuse & Mental Health Services Administration (SAMHSA)

Medicare/Medicaid

Patient access and maintain six protected classes for depressions and schizophrenia under Medicare Part D; Ensure patient access to behavioral health services and treatments through telehealth; H.R. 5376 - Inflation Reduction Act of 2022 - inflation penalty & redesign on Medicare Part D;

TargetedSENATE · HOUSE OF REPRESENTATIVES · Health & Human Services, Dept of (HHS) · Centers For Medicare and Medicaid Services (CMS)

Alcohol and Drug Abuse